Hsa-miR-134 Suppresses Non-small Cell Lung Cancer (NSCLC) Development Through Down-regulation Of CCND1
Cheng-Cao Sun, Shu-jun Li, Dejia Li
Published 2016 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Hsa-miRNA-134 (miR-134) has recently been discovered to have anticancer efficacy in different organs. However, the role of miR-134 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-134 on the development of NSCLC. The results indicated that miR-134 was significantly down-regulated in primary tumor tissues and very low levels were found in NSCLC cell lines. Ectopic expression of miR-134 in NSCLC cell lines significantly suppressed cell growth as evidenced by cell viability assay, colony formation assay and BrdU staining, through inhibition of cyclin D1, cyclin D2, CDK4 and up-regulation of p57(Kip2) and p21(Waf1/Cip1). In addition, miR-134 induced apoptosis, as indicated by concomitantly with up-regulation of key apoptosis protein cleaved caspase-3, and down-regulation of anti-apoptosis protein Bcl2. Moreover, miR-134 inhibited cellular migration and invasiveness through inhibition of matrix metalloproteinases (MMP)-7 and MMP-9. Further, oncogene CCND1 was revealed to be a putative target of miR-134, which was inversely correlated with miR-134 expression in NSCLC. Taken together, our results demonstrated that miR-134 played a pivotal role on NSCLC through inhibiting cell proliferation, migration, invasion, and promoting apoptosis by targeting oncogenic CCND1.
This paper references
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Jipeng Li (2012)
A MicroRNA precursor surveillance system in quality control of MicroRNA synthesis.
X Sherry Liu (2014)
Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.
Chengcao Sun (2016)
The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes
Bengt-Frederik Belgardt (2015)
miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
Zhongfei Li (2017)
MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis.
Sudipta Das (2014)
Inhibition of cyclin-dependent kinases by p21.
J. W. Harper (1995)
miR-134 induces oncogenicity and metastasis Oncotarget 35977 www.impactjournals.com/oncotarget in head and neck carcinoma through targeting WWOX gene
CJ Liu (2014)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
R. Johnstone (2008)
MicroRNA-21 inhibits p57Kip2 expression in prostate cancer
Sweta Mishra (2014)
MicroRNAs in Stress Signaling and Human Disease
Joshua T Mendell (2012)
Cyclin D 1 in non - small cell
Downregulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells
T Shuang (2015)
MicroRNAs as regulators of differentiation and cell fate decisions.
K. Ivey (2010)
MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
Lin Lu (2015)
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Yiyang Liu (2015)
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer
L. Zhang (2013)
High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model
Shi-mei Yuan (2015)
A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.
Juan C. Díaz-Martín (2014)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
J. Schiller (2002)
Tumour necrosis factor and cancer
F. Balkwill (2009)
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
Chengcao Sun (2015)
The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2
X. Zeng (2010)
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
P. Sicinski (1996)
Hepatocyte nuclear factor-4alpha reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology
C Yin (2013)
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
O. Gautschi (2007)
Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.
Chengcao Sun (2015)
MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation
Xiaoying Zhang (2012)
signals centrosome amplification in mammary epithelial cells through cyclin D 1 / Cdk 4 and Nek 2
P Sicinski (2010)
NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
S. Yan (2015)
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma
R Zha (2014)
Stem cell division is regulated by the microRNA pathway
S. Hatfield (2005)
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
X. Tang (2016)
miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis
Ke Chen (2015)
MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression
Chao-Shi Niu (2013)
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
Yongtao Gao (2015)
Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD).
Yuan Fu Qiu (2012)
Unambiguous identification of miRNA:target site interactions by different types of ligation reactions.
Stefanie Grosswendt (2014)
Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
A. Italiano (2009)
Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related www.impactjournals.com/oncotarget Factor 2 (Nrf2)-mediated Inhibition of NF-kappaB Signaling Pathway
C C Sun (2015)
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer
Yue Zhang (2014)
Transcriptional regulation of the p21((WAF1/CIP1)) gene.
A. Gartel (1999)
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
P. Holoch (2009)
WAF1, a potential mediator of p53 tumor suppression
W. El-Deiry (1993)
Methylation-induced loss of miR-484 in microsatellite-unstable colorectal cancer promotes both viability and IL-8 production via CD137L.
Q. Mei (2015)
MicroRNA expression profiles classify human cancers
J. Lu (2005)
Role of matrix metalloproteinases (MMPs) in colorectal cancer
S. Zucker (2004)
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A
Hongxia Chen (2014)
SMYD 3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D 2 through H 4 K 20 me 3
F. Vieira (2015)
Hsa-miR-326 targets CCND1 and inhibits nonsmall cell lung cancer
C Sun (2016)
miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis.
Chia-Yi Hsu (2014)
MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression.
Roberto Fiore (2014)
Specific protection against breast cancers by cyclin D1 ablation
Q. Yu (2001)
Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer
Cheng-Cao Sun (2016)
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Keith. O'Brien (2015)
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
Filipa Quintela Vieira (2015)
Cyclin D as a therapeutic target in cancer
E. Musgrove (2011)
MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Chengcao Sun (2016)
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
Chengcao Sun (2016)
MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway.
Tianjun Chen (2015)
Matrix metalloproteinases: effectors of development and normal physiology.
T. Vu (2000)
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
T. Wang (1994)
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
Chuan Yin (2013)
Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation
Chengcao Sun (2015)
Molecular genetics of lung cancer.
Y. Sekido (1988)
The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Yan Chen (2015)
Hepatocyte nuclear factor - 4 alpha reverses malignancy of hepatocellular carcinoma through regulating miR - 134 in the DLK 1 - DIO 3 region
C Yin (2013)
High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR134 on CD86 in a murine melanoma model. Oncotarget
SM Yuan (2015)
miR-134 induces oncogenicity and metastasis www.impactjournals.com/oncotarget in head and neck carcinoma through targeting WWOX gene
C J Liu (2014)
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
J. Harper (1993)
This paper is referenced by
miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
H. Huang (2020)
Circular RNA: a novel biomarker and therapeutic target for human cancers
Bo Lei (2019)
Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis.
Peng Song (2019)
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood
Ana Rita Lourenço (2017)
MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.
Shao-bo Ke (2018)
Circ_0078767 suppresses non‐small‐cell lung cancer by protecting RASSF1A expression via sponging miR‐330‐3p
T. Chen (2019)
Disease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion
Katharina Heßelbach (2017)
Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
Dan He (2019)
Advances of circular RNAs in carcinoma.
Xiao-Yue Xu (2018)
miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway.
Aiqin Qi (2019)
Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression.
Xiaojun Yang (2016)
Could miR-134 be a marker of ionizing radiation toxicity?
E. Jiménez-Mateos (2018)
DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer
Jhon R. Enterina (2017)
Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Jing Fang (2016)
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning
Wenbin Zhou (2017)
microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
Y. Li (2018)
The miR-875-5p inhibits SATB2 to promote the invasion of lung cancer cells.
J. Wang (2018)
miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.
Tianjun Chen (2017)
Highly expressed long non‐coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non‐small cell lung carcinoma
X Liu (2017)
A novel messenger RNA and long noncoding RNA signature associated with the progression of nonmuscle invasive bladder cancer.
Yu-hui He (2018)
Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression.
C. Zhang (2017)
MicroRNA‐30e‐5p suppresses non‐small cell lung cancer tumorigenesis by regulating USP22‐mediated Sirt1/JAK/STAT3 signaling
Gaojun Xu (2018)
Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.
Xiabin Lan (2018)
miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells
Kankan Chen (2018)
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors
Gary Wilk (2018)
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
C. Sun (2016)
Matrix metalloproteinases: their functional role in lung cancer.
N. Merchant (2017)
Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
Xinrui Shi (2016)
MicroRNA-134 Deactivates Hepatic Stellate Cells by Targeting TGF-β Activated Kinase 1-Binding Protein 1.
P. Wang (2019)
Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p
X. Zheng (2017)
Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
C. Zhang (2017)
The essential role of DICER in spermatogenesis and male fertility
Hanna Korhonen (2016)See more